Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €685.20 | €753.63 | 9.987% |
| Boston Scientific | 46 | 0 | 13 | 0 | €68.50 | €73.05 | 6.638% |
| Biogen Inc. | 43 | 1 | 3 | 0 | €195.30 | €294.45 | 50.767% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €350.70 | €370.00 | 5.503% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €462.95 | €543.72 | 17.447% |
| Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €536.00 | €566.65 | 5.718% |
| Merck & Co. Inc. | 28 | 1 | 5 | 0 | €122.60 | €124.93 | 1.900% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €80.77 | €88.14 | 9.122% |
| Humana Inc. | 23 | 0 | 6 | 0 | €286.00 | €439.88 | 53.803% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.50 | €85.64 | 39.258% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.00 | €95.79 | 5.269% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.35 | €294.28 | 16.617% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 3 | 0 | €75.64 | €102.62 | 35.668% |
| Resmed Inc. | 19 | 0 | 5 | 0 | €203.80 | €207.72 | 1.921% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €10.70 | €17.21 | 60.865% |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €116.18 | €136.82 | 17.767% |
| Sutro Biopharma Inc | 18 | 0 | 5 | 0 | €3.16 | €11.05 | 249.633% |
| HCA Holdings Inc. | 18 | 0 | 2 | 0 | €286.50 | €289.63 | 1.091% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €313.60 | €331.52 | 5.716% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €6.30 | - | - |